Mode
Text Size
Log in / Sign up
N/A N=167 Randomized Supportive Care

Efficacy Testing of a Culturally Relevant Stigma Intervention With WLWH in Tanzania

HIV · Stigma, Social · Self Efficacy · Self Esteem · Hope

Enrolled (actual)
167
Serious AEs
0.0%
Results posted
May 2025
Primary outcome: Primary: Number of Participants Recruited as Measured by Enrollment Logs — 80; 87 Participants

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Labda Siku Moja stigma reduction intervention (Behavioral)
Age
Adult, Older Adult · 18+ yrs
Sex
Female
Sponsor
Duke University
Primary completion
May 2024

Outcome Measures

OutcomeResultp-value
PRIMARY
Number of Participants Recruited as Measured by Enrollment Logs
80; 87
PRIMARY
Number of Study Participants Retained in Study as Measured by Enrollment Logs
77; 77; 79; 76; 76; 76
PRIMARY
Percent of Questions Left Blank on Study Instruments
0; 0; 0; 0; 0; 0
PRIMARY
Time it Takes in Minutes for Participants to Complete the Questionnaires
48; 49; 42; 41; 44; 42
PRIMARY
Number of Women Who Completed All 5 Sessions
76
SECONDARY
Change in Internalized Stigma, as Measured by the Swahili Version of the Multidimensional Measure of Internalized Stigma Scale
36.72; 40.18; 24.89; 6.01; 23.58; 5.21 <.0001 sig
SECONDARY
Change in Coping Self-efficacy, as Measured by the Swahili Version of the Coping Self-Efficacy Scale
13.28; 13.17; 14.4; 17.86; 14.9; 18.00 .002 sig
SECONDARY
Change in Self-esteem, as Measured by the Swahili Version of the Rosenberg Self-Esteem Scale
28.30; 28.17; 29.97; 32.66; 29.57; 32.26 .001 sig
SECONDARY
Hope, as Measured by the Swahili Version of the State of Hope Scale
15.48; 15.82 0.506
SECONDARY
Change in Depressive Symptoms, as Measured by the Swahili Version of the Patient Health Questionnaire 9
4.20; 4.63; 3.05; 2.09; 2.00; 1.77 .441

Summary

This study will test a stigma reduction intervention with women living with HIV in Tanzania.

Eligibility Criteria

Inclusion Criteria

The inclusion criteria for this study are:

  • (1) women who are living with HIV;
  • (2) age 18 (age of adulthood as defined by the Tanzanian government);
  • (3) able and willing to voluntarily consent to participate in the study;
  • (4) able to travel to a data collection in their local community (as described above);
  • (5) demonstrate mental competence at time of informed consent;
  • (6) verbally indicate that they plan to reside in their current community for at least 6 months after enrollment (necessary to prevent attrition);
  • (7) score at the median or higher level on the Swahili Version of the Multidimensional Measure of Internalized HIV Stigma Scale.

Exclusion Criteria

  • (1) any acute psychological or physiological distress; if there is evidence of acute psychologic and/or physiologic, they will be excluded from this study and referred to an appropriate site for evaluation and treatment.
  • (2) Transgender women living with HIV will not be eligible to participate in this study to reduce the potential for confounding sources of stigma recognizing that a transgender identity is highly stigmatized and culturally sensitive in Tanzania. Further, it would be exceedingly difficult to recruit a sufficient sample of transgender women living with HIV to conduct an appropriate analysis.
  • (3) Participants may be enrolled in other HIV-related studies except cognitive-behavioral intervention studies addressing stigma, self-efficacy, self-esteem, and/or disclosure
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05033002). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search